Vontobel Holding Ltd. Harmony Biosciences Holdings, Inc. Transaction History

Vontobel Holding Ltd.

  • $29.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
SELL
$29.93 - $35.06 $107,748 - $126,216
-3,600 Reduced 33.96%
7,000 $235,000
Q4 2023

Jun 03, 2024
BUY
$19.2 - $33.78 $69,120 - $121,608
3,600 Added 51.43%
10,600 $342,000
Q4 2023

Jan 29, 2024
BUY
$19.2 - $33.78 $69,120 - $121,608
3,600 Added 51.43%
10,600 $342,000
Q3 2023

Oct 10, 2023
BUY
$31.89 - $39.03 $223,230 - $273,210
7,000 New
7,000 $229,000
Q1 2021

May 11, 2021
BUY
$27.56 - $40.37 $275,600 - $403,700
10,000 New
10,000 $330,000

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.1M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email